UNSPSC 51142005: Methyl butetisalicylate

This classification denotes an analgesic.

UNSPSC 51142005 Methyl butetisalicylate, a Commodity code, shows little relevant recent activity under its nominal pharmaceutical ingredient scope. The three most recent state and local opportunities tagged to this code address naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceutical and OTC product distribution—none of which involve methyl butetisalicylate as a line item or active component. The mismatch suggests either miscoding in the source records or that this specific pharmaceutical ingredient sees minimal direct procurement attention from state and local agencies at present.

Activity appears concentrated in health and human services functions within Florida, Texas, and Minnesota. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas Health and Human Services Commission posted an RFI (HHS0017013, April 3, 2026) exploring direct-to-manufacturer prescription fulfillment; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers to state and local facilities across Minnesota and Oregon. Issuing bodies span county health departments, state health and human services agencies, and multistate cooperative purchasing vehicles. Without recent opportunities showing direct demand for methyl butetisalicylate under this code, activity assessment is not actionable at this time.